387570 — Finemedix Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Finemedix Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	—	240	1,176	-24.2	-1,878
Depreciation
Amortisation
Non-Cash Items	—	-535	279	637	-45.5
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital	210	-2,099	-1,041	-1,438	-1,672
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	210	-1,435	1,378	171	-2,634
Capital Expenditures	-1,228	-695	-336	-595	-853
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-371	2,469	883	720	-4,053
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-1,599	1,774	547	125	-4,907
Financing Cash Flow Items	-16	-80	—	-560	-30.7
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-613	-1,819	-1,215	8,167	266
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-1,976	-1,522	704	8,528	-7,274